Pushing Qcide as the front runner product, is exactly what we have been saying all along.
The inept board should have begun the registration process several years ago instead of chasing the synthesising process. Had they done the registration earlier then this would now be much further advanced and close to producing a cash flow.
Once again they are showing their lack of skill by the way they've written and released this announcement.
Yes, embarrassing again. (The Market reaction reflects what they have done.)
If they can get their act together properly with STK they can have Qcide registered in just over 2 years, not 3 years.
STK are the biggest in their field and have a far more clout, knowledge an experienced capable team. If BGT had any decent commercial nouse it could soon start to create a cash flow from the STK product range they now have access to as agents.
I can't believe the negative way RJ presented yesterday.
At least the light at the end of the tunnel has been turned on again but little will happen in the way of price valuation until they are much much closer to having a "registered" product
BGT Price at posting:
11.0¢ Sentiment: None Disclosure: Not Held
